Tag: technology

Malaysia’s exports projected to grow rapidly in 2026, driven by strong demand

Malaysia's exports projected to grow rapidly in 2026, driven by strong demand

KUALA LUMPUR, JULY 21 — RHB Investment Bank Bhd (RHB IB) has raised its 2026 export growth forecast for Malaysia to 21.7 percent from 15.3 percent previously, driven by stronger-than-expected 2026 export performance so far, when it grew 27.5 percent. In a research note on Monday, the investment bank explained that the upward revision was […]

Malaysia, China Strengthen STI Cooperation To Drive Innovation Commercialisation – MOSTI

PUTRAJAYA, June 22 -- Malaysia and China are committed to strengthening cooperation in science, technology and innovation (STI) to expand technology commercialisation opportunities and ensure that innovation outcomes are translated into sustainable economic impact. The Ministry of Science, Technology and Innovation (MOSTI) said the commitment was reached through  Malaysia-China’s 4th Joint Committee Meeting (JCM) on Science, Technology and Innovation, co-chaired by Science, Technology and Innovation Minister Datuk Chang Lih Kang and China’s representative Lin Xin today. MOSTI said both countries also agreed to enhance cooperation in strategic areas, including artificial intelligence (AI), biotechnology, green technology and advanced materials technology, while strengthening talent development and research capacity. “MOSTI hopes that this collaboration will expand commercialisation opportunities to ensure that innovation is translated into sustainable economic impact in line with the National Science, Technology and Innovation Policy (NSTIP),” MOSTI said in a statement. According to MOSTI, among the key agenda items discussed at the JCM were STI policy exchanges, technology transfer and research commercialisation cooperation, as well as updates on ongoing bilateral programmes. Among the key Malaysia-China bilateral initiatives is the Joint Research Programme (Second Series), which is funding eight Malaysian research projects in areas such as AI, green technology involving energy storage, biotechnology, particularly human vaccines, space technology and advanced materials technology. MOSTI said the meeting also reviewed the progress of the Malaysia-China Expertise Exchange Programme (First Series), which has involved 10 Malaysian researchers in critical technology fields, including AI, green technology (energy storage) and advanced materials technology. In addition, MOSTI said both countries discussed the implementation of the Malaysia-China Joint Laboratory on Emerging Technologies programme, which will focus on AI, blockchain technology, biotechnology, renewable energy and advanced materials technology, with the participation of academia, industry and research communities from both countries. In conjunction with the meeting, MOSTI, through the Academy of Sciences Malaysia, also announced the selection of 10 Malaysian researchers to participate in the Malaysia-China Expertise Exchange (MSE) programme, under which they will be placed for six months at selected research institutions, universities and companies in China. “The programme aims to strengthen local capabilities, enhance science diplomacy, expand bilateral research networks and build national capacity in strategic technologies in support of the country’s STI agenda,” the ministry said. It added that the JCM serves as a key platform for strengthening bilateral cooperation in STI under the Science, Technology and Innovation Cooperation Agreement signed by both countries in October 2013. The meeting also follows Chinese President Xi Jinping’s official visit to Malaysia on April 15-16, 2025, which witnessed the signing of two new memoranda of understanding (MoUs) - one on mutual support for the establishment of laboratories in emerging technologies, and another on cooperation in the application of the BeiDou Navigation Satellite System (BDS). -- BERNAMA  

PUTRAJAYA, June 22 — Malaysia and China are committed to strengthening cooperation in science, technology and innovation (STI) to expand technology commercialisation opportunities and ensure that innovation outcomes are translated into sustainable economic impact. The Ministry of Science, Technology and Innovation (MOSTI) said the commitment was reached through  Malaysia-China’s 4th Joint Committee Meeting (JCM) on Science, Technology […]

PMET Advances On-Site Lithium Refining Strategy Through Technology Collaboration MOU with Mitsui and MWCC

MOU to evaluate microwave calcination technology as a key enabling step in PMET's downstream strategy, leveraging the potential use of Québec's low-cost renewable hydroelectricity to support on-site lithium chemical processing MONTREAL, June 18 -- June 18, 2026 – Sydney, Australia Highlights PMET has entered into a non-binding Memorandum of Understanding ("MOU") with Mitsui & Co., Ltd. ("Mitsui") and Microwave Chemical Co., Ltd. ("MWCC") to jointly evaluate the application of MWCC's proprietary microwave calcination technology to produce higher-value lithium products on-site at Shaakichiuwaanaan. The collaboration builds on PMET's recently announced Concept Study (refer to News Release, 14 June 2026), which identified a potential pathway to produce battery-grade lithium carbonate at site and capture additional value within the lithium supply chain.   Microwave calcination has the potential to support electric calcination at site, which is the first step in the production of value-added lithium chemicals from spodumene concentrate, leveraging Québec's low-cost, renewable hydroelectric power as a potential alternative to conventional fossil fuel-based calcination. Pilot plant testing in Osaka will use spodumene samples supplied from Shaakichiuwaanaan, with MWCC leading the technical testing program and Mitsui supporting the evaluation of future commercialization and project development pathways. The initiative is aligned with PMET's longer term diversification strategy to reduce logistics intensity and enhance supply chain resilience, with potential benefits including reduced transportation requirements and lower truck traffic, reduced reliance on offshore conversion capacity, and the creation of a higher-value lithium product in Québec. The MOU is non-binding and non-exclusive, and any future commercial deployment remains subject to successful testing and demonstration at scale, technical and economic evaluation, definitive agreements, funding, permitting, approvals and other customary conditions. Ken Brinsden, CEO and Managing Director, comments: "This collaboration is a direct extension of the downstream growth strategy we outlined recently for Shaakichiuwaanaan. Our Concept Study identified a potential pathway to produce battery-grade lithium carbonate on site, and microwave calcination now represents an opportunity to evaluate one of the key enabling technologies that could support that vision. "Shaakichiuwaanaan is already one of the world's premier hard-rock lithium projects, and the collaboration with Mitsui and Microwave Chemical represents another important step in our strategy to evaluate additional value-creation opportunities beyond spodumene concentrate. "This MOU brings together PMET's high-quality lithium resource, MWCC's proprietary microwave calcination technology, and Mitsui's global project development and commercialization capabilities. It is an important next step in assessing how Shaakichiuwaanaan can leverage Québec's low-cost renewable hydroelectricity into a more integrated, Western-facing lithium supply chain that supports Québec, Canada and allied markets," added Mr. Brinsden. PMET Resources Inc. (the "Company" or "PMET") (TSX: PMET) (ASX: PMT) (OTCQX: PMETF) (FSE: R9GA) is pleased to announce that it has entered into a non-binding Memorandum of Understanding with Mitsui & Co., Ltd. and Microwave Chemical Co., Ltd. to jointly evaluate the application of proprietary microwave calcination technology to spodumene samples from the Company's 100%-owned Shaakichiuwaanaan Project, located in the Eeyou Istchee James Bay region of Québec, Canada. Background Calcination is a key initial processing step in the conversion of spodumene concentrate into downstream lithium chemicals, using heat to convert alpha-spodumene into beta-spodumene for subsequent lithium extraction. Historically, fossil fuels have been the key energy source (in the form of gas and/or coal) to create significant heat and the overall energy required to undertake the phase change (from alpha to beta spodumene). Mitsui & Co., Ltd. ("Mitsui") and Microwave Chemical Co., Ltd. ("MWCC") have launched a demonstration experiment for the joint development of microwave-based low-carbon lithium ore refining technology. Mitsui provides more information regarding their microwave calcination collaboration with MWCC, on their website. Québec's large-scale and renewable hydroelectricity scheme generates some of the lowest cost power available in North America. Harnessing this power for application in the spodumene calcination step (i.e. replacing fossil fuels) could represent a key source of competitive advantage for downstream initiatives and therefore motivates PMET Resources to continue its assessment of further value-added and downstream product initiatives at Shaakichiuwaanaan. Advancing PMET's Downstream Development Pathway On 14 June 2026, PMET announced the results of a Concept Study evaluating opportunities to convert spodumene concentrate produced at Shaakichiuwaanaan into higher-value lithium chemical products at site. The study identified Primero's ALi® atmospheric leach process as the preferred pathway for further evaluation and successfully produced 99.8% battery-grade lithium carbonate from Shaakichiuwaanaan spodumene concentrate at bench scale. A key conclusion of that work was that the combination of electric calcination and downstream lithium conversion could potentially leverage Québec's low-cost renewable hydroelectricity to create a more efficient and lower-carbon lithium supply chain while reducing logistics intensity and increasing value capture within Québec and Canada. The Mitsui-MWCC collaboration is intended to evaluate microwave-assisted electric calcination as a potential enabling technology within this broader downstream development strategy. PMET – MWCC – Mitsui & Co. MoU The MOU establishes a collaborative framework for the parties to advance technical evaluation, and potential future commercialization pathways for microwave calcination technology in the lithium industry. Under the terms of the MOU: PMET will supply spodumene raw material samples from Shaakichiuwaanaan for pilot plant testing, with 1.5 tonnes of 6.2% Li2O course spodumene concentrate already shipped to the Osaka pilot facility from its prior pilot DMS testwork programs. MWCC will lead the execution of pilot plant testing using its proprietary microwave calcination technology, and Mitsui will contribute to the evaluation of the pilot plant results from a project development perspective and where supported will facilitate discussions for potential future commercialization pathways. The collaboration is intended to assess whether microwave calcination could support PMET's broader value-added downstream products strategy, including the potential production of a lithium-enriched product at site. PMET believes Shaakichiuwaanaan is uniquely positioned to evaluate this opportunity given its scale, location in Québec, potential access to renewable hydroelectric power, and the potential to support a more integrated Western lithium chemicals supply chain. If successfully developed, electric calcination at or near the mine site could support the use of Québec's low-cost renewable power, reduce reliance on offshore conversion capacity, lower logistics intensity, and significantly reduce the amount of material transported from site by upgrading spodumene concentrate into a higher-value lower volume lithium product. The Company's concept study to date has identified meaningful potential benefits from on-site conversion, including reduced transport volumes, reduced logistics costs, reduced truck movements, and the potential to support a lower-carbon lithium chemical supply chain. The collaboration with Mitsui and MWCC is expected to focus specifically on the calcination stage as a potential enabling step in this broader downstream pathway. Following completion of pilot plant testing by MWCC, the parties expect to review the results and discuss whether to proceed with further evaluation and commercialization-oriented discussions relating to the potential application of microwave calcination technology to PMET's Shaakichiuwaanaan project. The parties may also coordinate efforts to evaluate potential government funding opportunities where aligned with critical minerals strategies and clean energy objectives. The MOU is non-binding and non-exclusive, except for customary provisions including confidentiality and related matters. Any future commercial arrangement, project development structure, technology deployment, financing or construction decision remains subject to successful testwork, further technical and economic evaluation, definitive agreements, required approvals, and customary development conditions.   About Mitsui & Co., Ltd. Mitsui & Co., Ltd. is a global trading and investment company with a diversified business portfolio and extensive experience in project development, commercialization, supply chain integration and industrial partnerships across natural resources, energy, infrastructure, mobility, chemicals and other sectors. About Microwave Chemical Co., Ltd. Microwave Chemical Co., Ltd. is a Japanese technology company focused on the development and commercialization of industrial microwave-based processes. Under the MOU, MWCC is expected to apply and validate its proprietary microwave calcination technology at pilot plant scale using spodumene samples supplied by PMET. About PMET Resources Inc. PMET Resources Inc. is a pegmatite critical mineral exploration and development company focused on advancing its district-scale 100%-owned Shaakichiuwaanaan Property located in the Eeyou Istchee James Bay region of Quebec, Canada, which is accessible year-round by all-season road and proximal to regional hydro-power infrastructure. In late 2025, the Company announced a positive lithium-only Feasibility Study on the CV5 Pegmatite for the Shaakichiuwaanaan Property and declared a maiden Mineral Reserve of 84.3 Mt at 1.26% Li2O (Probable)1. The study outlines the potential for a competitive and globally significant high-grade lithium project targeting up to ~800 ktpa spodumene concentrate using a simple Dense Media Separation ("DMS") only process flowsheet. Further, the results highlight Shaakichiuwaanaan as a potential North American critical mineral powerhouse with significant opportunity for tantalum and caesium in addition to lithium. The Project hosts a Consolidated Mineral Resource2 totalling 108.0 Mt at 1.40% Li2O and 166 ppm Ta2O5 (Indicated) and 33.4 Mt at 1.33% Li2O and 155 ppm Ta2O5 (Inferred) and ranks as a top ten lithium pegmatite globally in size. Additionally, the Project hosts the world's largest pollucite-hosted caesium pegmatite Mineral Resource at the Rigel and Vega zones with 0.69 Mt at 4.40% Cs2O (Indicated), and 1.70 Mt at 2.40% Cs2O (Inferred). For further information, please contact us at info@pmet.ca or by calling +1 (604) 279-8709, or visit www.pmet.ca. Please also refer to the Company's continuous disclosure filings, available under its profile at www.sedarplus.ca and www.asx.com.au, for available exploration data. This news release has been approved by "KEN BRINSDEN" Kenneth Brinsden, President, CEO, & Managing Director Disclaimer for Forward-Looking Information This news release contains "forward-looking statements" and "forward-looking information" within the meaning of applicable securities laws. All statements, other than statements of present or historical facts, are forward-looking statements. Forward-looking statements involve known and unknown risks, uncertainties and assumptions and accordingly, actual results could differ materially from those expressed or implied in such statements. You are hence cautioned not to place undue reliance on forward-looking statements. Forward-looking statements are typically identified by words such as "strategy", "to evaluate", "enabling step", "potential", "additional", "future", "development", "longer term", "remains subject to", "growth", "opportunities", "further", "advance", "intended", "expect" or variations of such words and phrases or statements that certain actions, events or results "may", "could", "would", "might" or "will" be taken, occur or be achieved.  Forward-looking statements include, but are not limited to, statements concerning microwave calcination and its potential,  the ability to implement PMET's longer term diversification strategy to reduce logistics intensity and enhance supply chain resilience, the ability to reduce transportation requirements and lower truck traffic, reduce reliance on offshore conversion capacity, and the creation of a higher-value lithium product in Québec, the success of any test, the ability to enter into definitive agreements and the ability to produce battery-grade lithium carbonate on site. Forward-looking statements are based upon certain assumptions and other important factors that, if untrue, could cause actual results to be materially different from future results expressed or implied by such statements. There can be no assurance that forward-looking statements will prove to be accurate. Key assumptions upon which the Company's forward-looking information is based include, without limitation, the ability to make discoveries, the potential of each of tantalum, lithium, caesium as a co-product, the ability to get approval for the Hydro-Québec power, the obtention of all required regulatory approvals, that proposed exploration work on the Property and the results therefrom will continue as expected, the accuracy of reserve and resource estimates, the classification of resources and the assumptions on which the reserve and resource estimates are based, long-term demand for lithium (spodumene), tantalum (tantalite), and caesium (pollucite)  supply, and that exploration and development results continue to support management's current plans for the Property's development. Forward-looking statements are also subject to risks and uncertainties facing the Company's business, any of which could have a material adverse effect on the Company's business, financial condition, results of operations and growth prospects. Readers should review the detailed risk discussion in the Company's most recent Annual Information Form filed on SEDAR+, for a fuller understanding of the risks and uncertainties that affect the Company's business and operations. Although the Company believes its expectations are based upon reasonable assumptions and has attempted to identify important factors that could cause actual actions, events or results to differ materially from those described in forward-looking statements, there may be other factors that cause actions, events or results not to be as anticipated, estimated or intended. There can be no assurance that forward-looking information will prove to be accurate. If any of the risks or uncertainties mentioned above, which are not exhaustive, materialize, actual results may vary materially from those anticipated in the forward-looking statements. The forward-looking statements contained herein are made only as of the date hereof. The Company disclaims any intention or obligation to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except to the extent required by applicable law. The Company qualifies all of its forward-looking statements by these cautionary statements. Competent Person Statement (ASX Listing Rules) The information in this news release that relates to the Feasibility Study ("FS") for the Shaakichiuwaanaan Project, which was first reported by the Company in a market announcement titled "PMET Resources Delivers Positive CV5 Lithium-Only Feasibility Study for its Large-Scale Shaakichiuwaanaan Project" dated October 20, 2025 (Montreal time) is available on the Company's website at www.pmet.ca, on SEDAR+ at www.sedarplus.ca and on the ASX website at www.asx.com.au. The production target from the Feasibility Study referred to in this news release was reported by the Company in accordance with ASX Listing Rule 5.16 on the date of the original announcement. The Company confirms that, as of the date of this news release, all material assumptions and technical parameters underpinning the production target in the original announcement continue to apply and have not materially changed. The Mineral Resource and Mineral Reserve Estimates in this release were first reported by the Company in accordance with ASX Listing Rules 5.8 and 5.9 in market announcements titled "World's Largest Pollucite-Hosted Caesium Pegmatite Deposit" dated July 20, 2025 (Montreal time) and "PMET Resources Delivers Positive CV5 Lithium-Only Feasibility Study for its Large-Scale Shaakichiuwaanaan Project" dated October 20, 2025 (Montreal time) and are available on the Company's website at www.pmet.ca, on SEDAR+ at www.sedarplus.ca and on the ASX website at www.asx.com.au. The Company confirms that, as of the date of this news release, it is not aware of any new information or data verified by the competent person that materially affects the information included in the relevant announcement and that all material assumptions and technical parameters underpinning the estimates in the relevant announcement continue to apply and have not materially changed. The Company confirms that, as at the date of this announcement, the form and context in which the competent person's findings are presented have not been materially modified from the original market announcement. CONTACT: Olivier Caza-Lapointe, Head, Investor Relations, T: +1 (514) 913-5264, E: ocazalapointe@pmet.ca -- PRNewswire -- Source: PMET Resources Inc.

MOU to evaluate microwave calcination technology as a key enabling step in PMET’s downstream strategy, leveraging the potential use of Québec’s low-cost renewable hydroelectricity to support on-site lithium chemical processing MONTREAL, June 18  – Sydney, Australia Highlights PMET has entered into a non-binding Memorandum of Understanding (“MOU”) with Mitsui & Co., Ltd. (“Mitsui”) and Microwave Chemical […]

Gas Supply For Domestic Use Remains Sufficient, Says Minister

KUALA LUMPUR, June 3 -- Malaysia’s gas supply remains sufficient for now, with the majority of the country’s electricity generation supported by domestic sources, according to Science, Technology and Innovation Minister Datuk Chang Lih Kang. He said authorities continue to monitor developments in the industry. “About 80 per cent of electricity generation in Malaysia is supported by domestic sources, so we are not too dependent on external supplies. “For now, supply is adequate, and there is no cause for major concern,” he told reporters after launching the ‘Revolutionising Industry with Graphene’ initiative here today. Meanwhile, Gas Malaysia Bhd president and chief executive officer Azli Mohamed said the industry is not facing any supply constraints, with the company’s primary source of gas coming from Petroliam Nasional Bhd (Petronas). “Our reliance on the Middle East is minimal. Our supply comes mainly from domestic sources and Australia. Essentially, there are no issues meeting industry demand, and we are able to supply our more than 1,000 customers,” he said. However, Azli noted that the industry could still face indirect challenges, including higher transportation costs and supply chain disruptions. He cited the rubber industry as an example, as it depends on raw materials sourced from countries such as South Korea and China. -- BERNAMA

KUALA LUMPUR, June 3 — Malaysia’s gas supply remains sufficient for now, with the majority of the country’s electricity generation supported by domestic sources, according to Science, Technology and Innovation Minister Datuk Chang Lih Kang. He said authorities continue to monitor developments in the industry. “About 80 per cent of electricity generation in Malaysia is […]

PROMISE Technology Brings Sustainability Focus to AI Storage at COMPUTEX 2026

TAIPEI, May 25, 2026 /PRNewswire/ -- PROMISE Technology, a global innovator in enterprise storage solutions, announced it will showcase its latest AI-optimized storage portfolio at COMPUTEX 2026, highlighting a strategic focus on performance, storage expansion, and energy efficiency. Taking place June 2–5 at the Taipei Nangang Exhibition Center, COMPUTEX 2026 is one of the world's premier technology exhibitions. PROMISE will host live demonstrations at Booth R0708 in Hall 2 (TaiNEX 2). PROMISE's latest solutions are engineered for enterprise, AI datacenters, surveillance, and media & entertainment environments. The company will demonstrate how intelligent storage architectures can address key AI infrastructure challenges—particularly power constraints and capacity expansion—while sustaining the high performance required for next-generation workloads. optimized storage with features like NVMeBoost and GreenBoost 2.0. Featured Products at COMPUTEX 2026 BoosTrak Series A purpose-built dual-node (Compute & Storage nodes), all-NVMe storage platform with RDMA/RoCE and 100/200/400GbE connectivity. Designed for ultra-low latency and high-throughput AI and datacenter workloads, it debuts the latest evolution of NVMeBoost™. VTrak 8206 NVMe All-Flash Built on PCIe Gen5 with NVMe-oF support, this enterprise platform is optimized for AI-driven applications and real-time analytics. Vess A8340 A fully integrated AI and intelligent surveillance platform powered by multi-GPU architecture and Intel® Xeon® 6 processors. With six PCIe Gen5 x16 slots, it combines storage, compute, and video analytics in a single scalable system. Pegasus5 R12 Pro A hybrid Thunderbolt™ 5 storage solution with 12 HDD bays and 2 NVMe SSD bays, delivering up to 6,000 MB/s for demanding 4K/8K production workflows. Pegasus5 N4 A portable Thunderbolt™ 5 NVMe device offering up to 80Gbps bandwidth and 6,000 MB/s speeds, ideal for mobile and on-location creative work. GreenBoost™ 2.0: Keep GPUs Busy. Not Power-Hungry By reducing storage power consumption, GreenBoost 2.0 enables higher GPU utilization and supports larger-scale AI deployments within existing power and cooling limits. Developed in collaboration with Toshiba, GreenBoost 2.0 integrates high-density JBOD architectures with energy-efficient, high-capacity HDDs to deliver a balanced approach to performance and sustainability. James Lee, CEO of PROMISE Technology, commented: "We are happy to continue working with Toshiba, beginning with GreenBoost 1.0 onward to GreenBoost 2.0, advancing AI-driven storage and sustainable infrastructure at COMPUTEX. As enterprises scale AI, power and cooling have become defining constraints. Through deep hardware and software integration, we are enabling customers to achieve both performance and energy efficiency at scale." Noriaki Katakura, Division President, Storage Products Division, Toshiba Electronics Components Taiwan Corporation added: "As AI drives rapid data growth, enterprises need higher density with lower energy consumption. Through our collaboration with PROMISE Technology, combining high-density JBOD architecture and GreenBoost 2.0 with Toshiba's high capacity NL HDDs, we deliver an efficient, scalable foundation for modern data centers. We look forward to advancing ecosystem collaboration to support AI workloads while meeting sustainability goals." NVMeBoost™ PROMISE proprietary feature NVMeBoost creates an optimized data pipeline—accelerating storage-to-GPU transfers while improving inter-GPU communication. NVMeBoost represents a major step forward in making GPU-accelerated storage and high-speed networking accessible to mainstream enterprises. Organizations can achieve breakthrough performance for AI and data-intensive workloads while leveraging existing infrastructure. For more information or to schedule a meeting at COMPUTEX 2026, visit www.promise.com Booth: R0708 About PROMISE Technology PROMISE Technology is a leading provider of high-performance storage solutions for enterprise, AI, surveillance, media & entertainment, and creative professionals. With a focus on innovation, reliability, and sustainability, PROMISE delivers intelligent storage architectures for the world's most demanding data environments. Source: PROMISE Technology

TAIPEI, May 25, 2026 /PRNewswire/ — PROMISE Technology, a global innovator in enterprise storage solutions, announced it will showcase its latest AI-optimized storage portfolio at COMPUTEX 2026, highlighting a strategic focus on performance, storage expansion, and energy efficiency. Taking place June 2–5 at the Taipei Nangang Exhibition Center, COMPUTEX 2026 is one of the world’s […]

Informa Markets Puts Bangkok at the Center of Southeast Asia’s Pharma Industry, Uniting 400 Exhibitors, Experts from 70 Countries at CPHI South East Asia

BANGKOK, May 24, 2026 /PRNewswire/ -- Informa Markets sets to organise CPHI South East Asia from 8–10 July 2026 at Queen Sirikit National Convention Center under the theme "The Gateway to the ASEAN Pharma Industry." The event is a comprehensive pharmaceutical manufacturing exhibition, technology showcase, and conference for Southeast Asia, featuring innovations from more than 400 companies worldwide. Highlights include international pavilion zones from eight markets, showcasing innovation trends from Mainland China, India, Indonesia, Malaysia, South Korea, Taiwan, Thailand, Vietnam, and Egypt. The event will also provide business matching opportunities and over 60 academic conference sessions. Organisers expect more than 10,000 visitors from over 70 countries during the three-day event, creating new business opportunities throughout the exhibition. Ms. Rungphech Chitanuwat, Regional Portfolio Director – ASEAN at Informa Markets said, "The pharmaceutical industry in Thailand continues to show strong growth potential, supported by several factors including the country's transition into a fully aged society, the increasing prevalence of non-communicable diseases (NCDs), healthcare system expansion, growth in medical tourism, and the use of essential medicines in hospitals under Thailand's universal healthcare system. In 2024, Thailand's pharmaceutical industry was valued at approximately THB 240 billion (around 6.9 billion dollars), and is projected to grow by 6–7% due to these supporting factors. Market research agencies also forecast that by 2030, the industry could reach a value of 480 billion baht or 13.9 billion dollars. Another key trend to watch is the increasing push from both the public and private sectors toward pharmaceutical development and innovation, including both generic drugs and newly developed medicines. This aligns with government efforts to strengthen pharmaceutical security. Pharmaceutical and healthcare security has therefore become a national policy priority aimed at raising public healthcare standards and strengthening the country's economy as Thailand seeks to join the OECD within five years. Policies also focus on reducing reliance on imported medicines, supporting domestic active pharmaceutical ingredient (API) production, and increasing manufacturing capacity for essential medicines in line with actual production costs. This is the driving force behind the organization of CPHI South East Asia, a technology and innovation exhibition with the important goal of contributing to Thailand's pharmaceutical security. The event aims to help drive both healthcare and the economy forward, positioning Thailand as a Medical Hub for Southeast Asia through internationally standardized pharmaceutical manufacturing and enhanced competitiveness in global export markets. Ms. Rungphech added, "Pharmaceutical security is a shared responsibility and a foundation of human security. Government and private sector must work in tandem to ensure Thailand not only has access to medicines, but becomes a country that the world trusts to produce them." "CPHI South East Asia is part of International Healthcare Week and will be held at Queen Sirikit National Convention Center from 8–10 July 2026 under the theme "The Gateway to the ASEAN Pharma Industry." The event will contribute to advancing Thailand's pharmaceutical industry in line with the country's strategic development goals." Ms. Supatra Boonserm, Secretary-General of the Food and Drug Administration (FDA), under the Food and Drug Administration Office (Thai FDA), Ministry of Public Health, stated that in a world where medical technology continues to advance rapidly, we are now entering the era of Advanced Therapy Medicinal Products (ATMPs). These are no longer just "medicines" in the traditional sense, but represent "new hope" for treating diseases once considered incurable — whether through cell therapy, gene therapy, or tissue engineering. Today, the role of the Thai FDA is no longer limited to being merely a "regulator" responsible for screening product safety. It has evolved into an "Innovation Facilitator," aiming to position Thailand as a true regional healthcare hub. The FDA's key mission in supporting ATMPs is built upon three major pillars: 1.Creating a Regulatory "Fast Track" (Regulatory Excellence) Complex innovations require regulations that are both flexible and rigorous. The FDA has therefore developed legal frameworks aligned with international standards, covering product classification and dedicated GMP standards specifically for ATMPs. This ensures that products developed by Thai innovators meet global standards and can confidently compete in international markets. 2. Serving as a Strategic Partner for Researchers and Entrepreneurs (Proactive Partnership) The FDA has implemented a Pre-submission Consultation mechanism to provide technical guidance before formal approval applications are submitted. It has also introduced Fast Track pathways for products addressing urgent medical needs, helping reduce unnecessary delays and barriers while maintaining patient safety as the highest priority. 3. Building an "Ecosystem of Trust" (Ecosystem of Trust) The FDA oversees clinical trials to ensure ethical compliance and maintains long-term post-market safety monitoring systems. This is intended to build confidence among both patients and healthcare professionals that these innovations will remain effective and safe in a sustainable manner. Mr. Surachai Ruengsuksilp, Honorary Chairman of the Pharmaceutical Industry Group under the Federation of Thai Industries and Vice President of the Thai Pharmaceutical Manufacturers Association (TPMA), stated that the pharmaceutical industry is not merely an economic driver, but also a "critical infrastructure for national security." Currently, Thailand's pharmaceutical market is valued at more than THB 240 billion. Amid these opportunities, the Federation of Thai Industries has established a strategic direction to position Thailand as a full-fledged Regional Pharma Hub through three key strategies: 1.Transforming from an "Importer" to a "Producer for Security" Reducing dependence on imported medicines by promoting domestic production of Active Pharmaceutical Ingredients (APIs), thereby reducing vulnerability to global crises. 2. Upgrading from "Basic Medicines" to "Advanced Innovation" Supporting Thai pharmaceutical manufacturers in upgrading to internationally recognized PIC/S GMP standards, enabling Thai medicines not only to serve the CLMV market but also to expand exports globally. 3. Building a Strong Pharmaceutical Ecosystem Driving collaboration with the government and the Board of Investment (BOI) to create an investment environment conducive to research and development, while also reforming procurement regulations to better reflect actual quality-based costs. This is intended to help Thai pharmaceutical companies remain competitive and achieve sustainable growth. The Federation of Thai Industries aims to make Thailand "a regional production base for high-quality and affordable medicines," focusing not only on economic growth figures, but also on ensuring that Thai people have sufficient access to safe medicines under all circumstances. Dr.Ponthip Wirachwong Ph.D. Deputy Managing Director, Government Pharmaceutical Organization (GPO), stated that beyond its primary role in pharmaceutical manufacturing, the organization's core mission is to ensure confidence in Thailand's healthcare system by guaranteeing that Thai people will never face medicine shortages during crises or at any time. In the past, Thailand has experienced epidemics and natural disasters, and the GPO has maintained reserve systems for essential medicines and medical supplies to ensure that hospital operations can continue without disruption caused by delays. "Even the most advanced medicine fails if it remains out of reach. GPO's mission is simple: ensure every Thai patient has access to safe, quality medicines — at a price that doesn't force them to choose between health and survival," she said. -- SOURCE : Informa Markets

BANGKOK, May 24, 2026 /PRNewswire/ — Informa Markets sets to organise CPHI South East Asia from 8–10 July 2026 at Queen Sirikit National Convention Center under the theme “The Gateway to the ASEAN Pharma Industry.” The event is a comprehensive pharmaceutical manufacturing exhibition, technology showcase, and conference for Southeast Asia, featuring innovations from more than […]

HSA 2026 To Serve As Platform To Boost Ecosystem, Public-Private Healthcare Collaboration

KUALA LUMPUR, May 20 -- The hosting of the Health Summit Asia (HSA) 2026 is expected to serve as a catalyst in strengthening the regional healthcare ecosystem through the gathering of industry players, medical technology experts and policymakers from within and outside the country to explore future healthcare solutions. Deputy Health Minister Datuk Hanifah Hajar Taib said the platform would also create opportunities for stronger collaboration between the government and private sector in enhancing the national healthcare system, particularly through the sharing of technology, innovation and the latest expertise. She said through exhibitions and discussion sessions involving local and international industry players, various new technologies and innovations in the healthcare sector could be highlighted not only in Malaysia but also across Asia. “If we think about it, it is not necessarily the Ministry of Health (MOH) or the Malaysian government that knows every type of technology or breakthrough available from other countries or local industries. “So through exhibitions and discussions like this, we can further strengthen understanding and facilitate solutions to more complex health problems,” she told reporters after launching HSA 2026 here today. Also present were Green Wellness Malaysia founder and managing director Datin Dorph Peng and Qube Integrated Malaysia executive chairman Richard Teo. The three-day conference, jointly organised by Qube Integrated Malaysia and Green Wellness Malaysia, is expected to attract more than 10,000 delegates, over 100 exhibitors and participation from more than 40 global and regional speakers, while targeting the generation of up to RM1.5 billion in commercial opportunities within the ASEAN healthcare and wellness economy. Meanwhile, commenting on the issue of drug-laced vapes or “zombie vapes”, Hanifah Hajar said MOH continuously monitors the current situation while conducting awareness programmes in schools to educate students on the dangers of vaping to health. “If there are vapes containing drugs and not produced by registered companies, we need to work together with the police, customs and enforcement authorities to ensure such matters cannot be compromised,” she said. On the Ebola situation, she said the Ebola vaccine has yet to be registered in Malaysia, but the ministry is making early preparations, including identifying procurement and logistics processes should the vaccine be required in the future. “We want to ensure that if needed, we are fully prepared to bring the vaccine into Malaysia,” she said. Earlier, MOH in a statement today said no Ebola cases have been reported in Malaysia so far, but preparedness measures are being further strengthened in view of the risk of imported cases through international travel following outbreaks in Congo and Uganda. -- BERNAMA

KUALA LUMPUR, May 20 — The hosting of the Health Summit Asia (HSA) 2026 is expected to serve as a catalyst in strengthening the regional healthcare ecosystem through the gathering of industry players, medical technology experts and policymakers from within and outside the country to explore future healthcare solutions. Deputy Health Minister Datuk Hanifah Hajar […]

Ujana Tenaga PETRONAS Chronicles Terengganu’s Energy Journey

KUALA TERENGGANU, May 19– The Petroleum Gallery at the Terengganu State Museum, which has been upgraded to Ujana Tenaga PETRONAS (PETRONAS Energy Garden), chronicles the story of energy, PETRONAS’ heritage, and technological advancement in a way that resonates with the public. PETRONAS senior vice president (Project Delivery and Technology) Ir. Mohd Yusri Mohamed Yusof said […]